<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Clinicopathological Features of Non-metastatic Triple Negative Breast Cancer</title>
	<subject_fa>Adults Hematology &amp; Oncology</subject_fa>
	<subject>Adults Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Triple negative breast cancer (TNBC) is reported to be associated with a high risk of recurrence, poor overall survival (OS), and disease-free survival (DFS) rates. This study evaluated the clincopathological features and survival of non-metastatic TNBC women in the capital of Iran compared with other areas of the world.&lt;br&gt;
Methods: In a retrospective study, 119 women with TNBC based on the criteria were analyzed in this study during 2007-2015. A number of clinicopathological variables, OS and DFS were determined in all patients. The mean follow-up was 38 months, which 6 patients lost to follow-up and 16 died of the disease and therefore were censored from the study.&amp;nbsp;&lt;br&gt;
Results: The mean age at diagnosis was 44.9 years (range: 21-85 years). 31.9% were older than 50 years. The 2- and 5-years OS rates were 96% and 88.1%, respectively; whereas, the 2- and 5-years DFS rates were 87% and 74.1%, respectively. Right breast tumor and lymph node involvement were more common in patients younger than 50 years, but vascular invasion was more observed in patients aged &amp;ge;50 years. There was no significant difference between menopause status, age and Ki-67 index for OS or DFS.&amp;nbsp;&lt;br&gt;
Conclusion: The prevalence of TNBC was more common in women younger than 50 years. Ki-67 index, menopausal status and age could contribute to prognosis and survival of patients.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Breast cancer, Overall survival, Disease free survival, Prognostic factors, Triple negative, Estrogen receptor, Progesterone receptor, HER2 receptors</keyword>
	<start_page>18</start_page>
	<end_page>23</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-218-13&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Safa</first_name>
	<middle_name></middle_name>
	<last_name>Najafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>safa3n@yahoo.com</email>
	<code>10031947532846003577</code>
	<orcid>10031947532846003577</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Breast Cancer Research Centre, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamid Reza</first_name>
	<middle_name></middle_name>
	<last_name>Mozaffari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mozaffari20@yahoo.com</email>
	<code>10031947532846003578</code>
	<orcid>10031947532846003578</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Oral Medicine, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Masoud</first_name>
	<middle_name></middle_name>
	<last_name>Sadeghi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sadeghi_mbrc@yahoo.com</email>
	<code>10031947532846003579</code>
	<orcid>10031947532846003579</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
